EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intrahippocampally Injected Human Recombinant Clusterin Reduces Amyloid‐β Aggregate Size in Cerebral Arteriole Walls of Clusterin Knockout Mice

Alexandru Laslo, Tudor-Gabriel Boghițoiu, Laura Chinezu, Doina Manu, Adrian Dumitru Ivanescu, Bogdan Andrei Cordoș, Mark R Wilson, Claudia Banescu, John D Fryer, Ajay Verma, Jennifer M Dewing iD, Roxana-Octavia Carare

Neuropathology and Applied Neurobiology · 2025

DOI: 10.1111/nan.70037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, 2025. Verfasst von Alexandru Laslo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, Târgu Mureș, Romania. Hauptthemen laut MEDLINE: Clusterin, Amyloid beta-Peptides, Hippocampus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Agency UEFISCDI, Alzheimer's Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The clusterin ( CLU ) gene is genetically associated with Alzheimer's disease ( AD ), and CLU levels have been shown to positively correlate with regional Aβ deposition in the brain, including in arteries from cerebral amyloid angiopathy (CAA) patients. CLU has also been shown to alter the aggregation, toxicity and blood–brain barrier transport of amyloid beta (Aβ) and has therefore been suggested to play a key role in regulating the balance between Aβ deposition and clearance in both the brain and cerebral blood vessels. However, it remains unclear whether the role of clusterin in relation to Aβ deposition is protective or pathogenic. The aim of this study was to determine how the presence of clusterin influences the pattern of Aβ deposition in hippocampal cerebral vessels.

Methods

Intrahippocampal injections of fluorescent human recombinant Aβ alone or in combination with human recombinant CLU were carried out in Clu knockout mice. Aβ deposition and aggregate size in arterioles and capillaries were assessed by confocal microscopy.

Results

The presence of CLU significantly reduced the size of Aβ deposits in the walls of cerebral arterioles but not in the tissue outside arterioles. There was no significant difference in overall Aβ deposition within cerebral arterioles and capillaries of mice injected with Aβ + CLU versus Aβ alone.

Conclusions

Our findings confirm that CLU directly impacts cerebral vascular Aβ aggregation, the implications of which are particularly relevant to CAA, which is a major cause of cerebral haemorrhage and cognitive decline, particularly in individuals with AD .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClusterinAmyloid beta-PeptidesHippocampusAnimalsMice, KnockoutMiceHumansArteriolesAlzheimer DiseaseMaleMice, Inbred C57BLCerebral Amyloid Angiopathy

Stichwörter der Autor:innen

amyloid beta (Aβ)clusterinconfocal microscopyintramural periarterial drainage

Substanzen

ClusterinAmyloid beta-PeptidesCLU protein, human

Autor:innen und Institutionen

  • Department of Urology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, Târgu Mureș, Romania.
  • Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, Târgu Mureș, Romania.
  • Psychiatry Clinic 2, Mures County Clinical Hospital, Târgu Mureș, Romania.
  • Department of Histology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, Târgu Mureș, Romania.
  • Center for Advanced Medical and Pharmaceutical Research, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, Târgu Mureș, Romania.
  • Department of Anatomy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, Târgu Mureș, Romania.

ORCID-Profile: Jennifer M Dewing

Förderung

  • National Agency UEFISCDI
  • Alzheimer's Society

Zitieren

APA

Laslo, A., Boghițoiu, T. G., Chinezu, L., Manu, D., Dumitru Ivanescu, A., Cordoș, B. A., Wilson, M. R., Banescu, C., Fryer, J. D., Verma, A., Dewing, J. M., & Carare, R. O. (2025). Intrahippocampally Injected Human Recombinant Clusterin Reduces Amyloid‐β Aggregate Size in Cerebral Arteriole Walls of Clusterin Knockout Mice. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.70037

Vancouver

Laslo A, Boghițoiu TG, Chinezu L, Manu D, Dumitru Ivanescu A, Cordoș BA, et al. Intrahippocampally Injected Human Recombinant Clusterin Reduces Amyloid‐β Aggregate Size in Cerebral Arteriole Walls of Clusterin Knockout Mice. Neuropathology and Applied Neurobiology. 2025. doi:10.1111/nan.70037

BibTeX
@article{Laslo2025,
  author = {Laslo, Alexandru and Boghițoiu, Tudor-Gabriel and Chinezu, Laura and Manu, Doina and Dumitru Ivanescu, Adrian and Cordoș, Bogdan Andrei and Wilson, Mark R and Banescu, Claudia and Fryer, John D and Verma, Ajay and Dewing, Jennifer M and Carare, Roxana-Octavia},
  title = {Intrahippocampally Injected Human Recombinant Clusterin Reduces Amyloid‐β Aggregate Size in Cerebral Arteriole Walls of Clusterin Knockout Mice},
  journal = {Neuropathology and Applied Neurobiology},
  year = {2025},
  doi = {10.1111/nan.70037}
}
Kostenlos starten →